
The Food and Drug Administration has recently approved a new treatment for Alzheimer’s disease. The drug is the first in 18 years to receive FDA approval for the treatment of Alzheimer’s, but has attracted controversy over its efficacy and high cost. Experts estimate that the drug could cost the federal... Read More »